Korean Drugmakers at a Crossroads

Published: 2012-03-16 06:58:00

Updated: 2012-03-16 06:58:00

Many experts say that coupled with the government’s plan to slash insurance drug prices, the country's medicine business is standing at a crossroads as the free trade pact between Korea and the United States takes effect from today; Is it going take a leap with new, innovative drugs or continue c...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK